Bicalutamide 50 mg Tablets (Bicatero 50) – Oncology Export Supplier

Bicalutamide 50 mg tablets are prescription-only oral oncology medicines formulated for use within regulated cancer treatment frameworks. Marketed under the brand name Bicatero 50, this product contains Bicalutamide, a non-steroidal antiandrogen used in hormone-related oncology care. Bicalutamide 50 mg tablets are manufactured for hospital and institutional supply and are offered strictly for international export to licensed pharmaceutical distributors, hospitals, and oncology treatment centers. AmeriDrugs does not supply this product for retail sale or direct patient use.

Active Ingredient

• Bicalutamide – 50 mg per tablet
  Bicalutamide is a non-steroidal antiandrogen that inhibits androgen receptor activity and is used under approved oncology indications.

Therapeutic Use

From an informational and regulatory perspective, Bicalutamide 50 mg tablets are used in approved oncology settings related to prostate cancer management, as defined by regulatory authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment recommendations, or patient-level guidance related to Bicalutamide 50 mg tablets.

Dosage Form

• Oral solid dosage form

• Film-coated tablets

• Supplied in unit-dose packaging suitable for hospital and institutional pharmacy use

• Administration and treatment decisions are determined exclusively by qualified oncology professionals in accordance with local regulations

Quality & Manufacturing Standards

Bicalutamide 50 mg tablets (Bicatero 50) are manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Manufacturing processes include raw material qualification, in-process controls, and finished product testing to ensure identity, strength, purity, and consistency aligned with international export standards for Bicalutamide 50 mg tablets.

Packaging Information

• Pack size: 1 × 10 tablets

• Pharmaceutical-grade blister packaging

• Secure secondary packaging designed for international transport

• Labeling compliant with prescription oncology medicine regulations

Target Buyers

This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and oncology treatment centers

• Government and private cancer care institutions

• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note

Bicalutamide 50 mg tablets (Bicatero 50) are prescription-only oncology medicines. Importation, distribution, and use must comply with the pharmaceutical laws, oral oncology drug regulations, and oncology approvals of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote Bicalutamide 50 mg tablets for self-medication or any non-regulated use.